Goldman Sachs
New York City | U.S.A.
| Investor Type | Firm |
| Industries | Software (Web Marketplace Saas..) • FinTech (& Financials services) • Retail (& E-Commerce) • Blockchain (& Cryptos) • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Payments • Online Social |
| Investing | U.S.A. |
| Investment Range | $5,000 - $7,000,000,000 |
| Investment Sweet Spot | $10,000 |
About The Fund
Goldman Sachs is a global leader in corporate equity investing. Since 1986, Goldman Sachs Sachs and its predecessor business have invested over $82 billion of equity in over 600 companies globally. Goldman Sachs is currently investing its GS Capital Partners VI fund, comprised of $20 billion of equity, including over $7.4 billion of capital from Goldman Sachs. The fund invests across a broad range of industries in the Americas, Europe and Asia with investment targets ranging from $50 million to $800 million. In addition, the technology group within Goldman Sachs Principal Investment Area, invests in innovative technology companies across the many stages of a company's lifecycle. As of December 31, 2008 the Goldman Sachs Private Equity Group (PEG) managed over $32.8 billion across primary commitments, co-investments and secondary-market investments, with over $2.0 billion invested by Goldman Sachs and its employees. Private Capital Investing (PCI) is Goldman Sachs' investment platform dedicated to providing preferred equity and mezzanine capital to growth and middle market companies based in North America. PCI invests $20 million - $150 million of equity per transaction in the form of common, preferred, and structured equity.
Goldman Sachs's investments on record
| Agari | $40,000,000.00 | Series E |
| Stackline | $50,000,000.00 | Series A |
| Sixup | $13,000,000.00 | Debt Financing |
| Xiaojingtouxi | $15,000,000.00 | Series A |
| Silver Creek Pharmaceuticals | $20,000,000.00 | Venture Round |
| Visible Alpha | $38,000,000.00 | Venture Round |
| Rimag | $64,000,000.00 | Series B |
| Ripple Foods | $65,000,000.00 | Series C |
| MedPlus | $117,670,000.00 | Debt Financing |
